ooooops,,,I will appologize to the board for my stupid question,,,however,,,I read every one of your posts here and everyone elses for that matter and the format of releasing news to the markets by biotech I believe has been understood. My post was questioning the why in the format. Not what generally takes place at a trials' data release. Since we previously employeed a third party to analyze our post hoc data from the Assure trial I will assume we will employ the same on the BoM trial. RVX needs every bit of good news front and center in FEB or March or April or H1 when ever this release takes place imo. We have debts to pay under contract and substantial $$$ to raise to carry on this crusade in what would be expected to be a reasonable timeline to shareholders and those in need of this technology.,,and agian its just an opinion,, Ill try not to ask such in the future, but no guarantees!! :o)